ArticleBiomaterials and biosystems2025
Integrated approach to cell growth and recovery in silk fibroin scaffolds via a spin-down system.
Article in Biomaterials and biosystems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biomedical titanium-tantalum alloys for orthopedic implant applications: From manufacturing to biological performance.Bioactive materials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silk fibroin scaffolds are a versatile platform for biomedical applications due to their biocompatibility and tunable properties. Successful clinical translation requires standardized production and characterization methods to ensure high reproducibility in cell seeding, growth profiling and recovery for downstream analysis. The intrinsic autofluorescence of silk and the limited diffusion of reagents through its porous structure present significant challenges for conventional assays, such as cell viability tests, DNA quantification, and optical imaging-based approaches. These assays are a requirement for validation procedures and characterization. In this study, we introduce a standardized protocol for efficiently assessing cell seeding and growth behavior. By analyzing the physicochemical properties of the silk sponge, we determined the optimal volumes required for silk swelling and cell seeding. Additionally, we developed a spin-down system that enables the application of endpoint assays while ensuring gentle cell recovery. We established and experimentally validated the relationship between silk sponge volume and the growth limitations of embedded cells. Overall, this study underscores the importance of a standardized procedure for efficient cell seeding and recovery, ultimately facilitating clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.